Myasthenia gravis (MG) and inflammatory myopathy (IM) are distinct autoimmune diseases that rarely coexist. By 2020, fewer than 70 cases of MG-IM overlap had been reported, most with thymic abnormalities.1 MG-IM overlap has also been recognized as an immune-related adverse event from immune checkpoint inhibitor therapy.2
No takes yet. Share an insight, caveat, or question.
Jammal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: